The current achievements in treating glioblastoma (GBM) patients are not sufficient because
many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem …

The main developments on nano-emulsion formation by low-energy methods in the last five
years are reviewed. A general description on nano-emulsions, including issues such as size …

The structural and chemical uniformity of traditional emulsions facilitates their production;
however, this simplicity also limits the scope of their applications. Multiphase or …

There has been a resurgence of interest in nanoemulsions for various pharmaceutical
applications since low-energy emulsification methods, such as spontaneous or self …

Glioblastoma is the most aggressive form of brain tumor, accounting for the highest mortality
and morbidity rates. Current treatment for patients with glioblastoma includes maximal safe …

Glioblastoma (GBM) is an aggressive malignancy of the central nervous system (CNS) that
remains incurable despite the multitude of improvements in cancer therapeutics. The …

Nanostructured products are an actively growing area for food research, but there is little
information on the sustainability of processes used to make these products. In this Review …

Nanoformulations have attracted a lot of attention because of their size-dependent
properties. Among the array of nanoformulations, lipid nanoformulations (LNFs) have …

Peptides are therapeutic molecules that can treat selectively and efficiently a wide range of
pathologies. However, their intrinsic properties cause their rapid degradation in the human …

During the last decades, the focus of research in pharmaceutical technology has steadily
shifted towards the development and optimisation of nano-scale drug delivery systems. As a …